ImmunoPrecise Antibodies is an integrated antibody solutions CRO that provides services across the full antibody discovery value chain (antigen design, hit generation, lead selection, lead optimization and lead characterization). ImmunoPrecise offers the most comprehensive collection of antibody discovery platforms in the industry (Single B cell, transgenic animals platforms, library-based display and advanced hybridoma based technologies). When combined with state of the art lead candidate optimization and characterization, ImmunoPrecise can assist clients from the moment they identify a therapeutic target to the time they are preparing to apply for investigation review of the clinical product.

ImmuoPrecise’s proprietary next generation technologies enable antibody screening from any species of animal. By running multiple species campaigns, ImmunoPrecise can provide a greater diversity of antibody repertoires and expand the breadth of its epitope coverage. This ensures the end goal of producing target specific antibodies against all classes of therapeutically relevant proteins, including complex targets such as GPCRs and ion channels. ImmunoPrecise is the first single source full-service antibody discovery CRO in North America or Europe to provide the complete service cycle for therapeutic antibody discovery.